Suppr超能文献

晚期癌症患者中东部肿瘤协作组体能状态(ECOG-PS)、改良格拉斯哥预后评分(mGPS)、体重指数/体重减轻分级(BMI/WL Grade)与身体成分及身体功能之间的关系

The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer.

作者信息

Dolan Ross D, Daly Louise E, Simmons Claribel Pl, Ryan Aoife M, Sim Wei Mj, Fallon Marie, Power Derek G, Wilcock Andrew, Maddocks Matthew, Bennett Michael I, Usborne Caroline, Laird Barry J, McMillan Donald C

机构信息

Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2ER, UK.

School of Food and Nutritional Sciences, College of Science, Engineering and Food Science, University College Cork, Cork, Ireland.

出版信息

Cancers (Basel). 2020 May 8;12(5):1187. doi: 10.3390/cancers12051187.

Abstract

Cancer remains one of the leading causes of mortality worldwide and the associated reduction in physical function has a marked impact on both quality of life and survival. The aim of the present study was to examine the relationship between Eastern Cooperative Oncology Group-Performance status (ECOG-PS), modified Glasgow Prognostic Score (mGPS), Body Mass Index/ Weight Loss grade (BMI/WL grade), and Computerised Tomography (CT)-derived body composition measurement and physical function in patients with advanced cancer. Nine sites contributed prospective data on patient demographics, ECOG-PS, mGPS, physical function tests, and CT-derived body composition. Categorical variables were analysed using χ test for linear-by-linear association, or χ test for 2-by-2 tables. Associations were analysed using binary logistic regression. A total of 523 cancer patients (266 males, 257 females) were included in the final analysis and most had metastatic disease (83.2%). The median overall survival was 5.6 months. On multivariate binary logistic regression analysis, a high ECOG-PS remained independently associated with a low skeletal muscle index ( < 0.001), low skeletal muscle density ( < 0.05), and timed up and go test failure ( < 0.001). A high mGPS remained independently associated with a low skeletal muscle density ( < 0.05) and hand grip strength test failure ( < 0.01). A high BMI/WL grade remained independently associated with a low subcutaneous fat index ( < 0.05), low visceral obesity ( < 0.01), and low skeletal muscle density ( < 0.05). In conclusion, a high ECOG-PS and a high mGPS as outlined in the ECOG-PS/mGPS framework were consistently associated with poorer body composition and physical function in patients with advanced cancer.

摘要

癌症仍然是全球主要的死亡原因之一,与之相关的身体功能下降对生活质量和生存率都有显著影响。本研究的目的是探讨东部肿瘤协作组体能状态(ECOG-PS)、改良格拉斯哥预后评分(mGPS)、体重指数/体重减轻分级(BMI/WL分级)以及计算机断层扫描(CT)得出的身体成分测量值与晚期癌症患者身体功能之间的关系。九个研究点提供了关于患者人口统计学、ECOG-PS、mGPS、身体功能测试以及CT得出的身体成分的前瞻性数据。分类变量使用线性趋势的χ检验或2×2列联表的χ检验进行分析。关联性分析采用二元逻辑回归。最终分析纳入了523例癌症患者(266例男性,257例女性),大多数患者患有转移性疾病(83.2%)。中位总生存期为5.6个月。在多变量二元逻辑回归分析中,高ECOG-PS仍然独立地与低骨骼肌指数(<0.001)、低骨骼肌密度(<0.05)以及计时起立行走测试失败(<0.001)相关。高mGPS仍然独立地与低骨骼肌密度(<0.05)和握力测试失败(<0.01)相关。高BMI/WL分级仍然独立地与低皮下脂肪指数(<0.05)、低内脏肥胖(<0.01)和低骨骼肌密度(<0.05)相关。总之,在ECOG-PS/mGPS框架中概述的高ECOG-PS和高mGPS与晚期癌症患者较差的身体成分和身体功能始终相关。

相似文献

4
Determinants of quality of life in patients with incurable cancer.无法治愈癌症患者生活质量的决定因素。
Cancer. 2020 Jun 15;126(12):2872-2882. doi: 10.1002/cncr.32824. Epub 2020 Apr 8.
5
Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.炎症和体能状态:晚期癌症预后的基石。
J Pain Symptom Manage. 2023 Apr;65(4):348-357. doi: 10.1016/j.jpainsymman.2022.11.021. Epub 2022 Dec 7.

引用本文的文献

1
The Influence of Muscle Morphology on Oncological Outcomes: A Review.肌肉形态对肿瘤学结局的影响:综述
J Frailty Sarcopenia Falls. 2025 Sep 1;10(3):163-199. doi: 10.22540/JFSF-10-163. eCollection 2025 Sep.

本文引用的文献

1
Determinants of quality of life in patients with incurable cancer.无法治愈癌症患者生活质量的决定因素。
Cancer. 2020 Jun 15;126(12):2872-2882. doi: 10.1002/cncr.32824. Epub 2020 Apr 8.
7
Prognostication in advanced cancer: update and directions for future research.晚期癌症的预后:更新及未来研究方向。
Support Care Cancer. 2019 Jun;27(6):1973-1984. doi: 10.1007/s00520-019-04727-y. Epub 2019 Mar 13.
10
Endpoints in clinical trials in cancer cachexia: where to start?癌症恶病质临床试验的终点指标:从何入手?
Curr Opin Support Palliat Care. 2018 Dec;12(4):445-452. doi: 10.1097/SPC.0000000000000387.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验